Adjuvant Radiotherapy and Survival After Breast-Conserving Surgery in Women Aged ≥70 Years with Hormone Receptor–Positive T1–2N0M0 Breast Cancer: A Propensity Score–Matched SEER Study
International Journal of Women's Health · 2026-11 · Volume 18 · 1-13
DOI: 10.2147/ijwh.s652389 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Women's Health, 2026-11. Verfasst von Linyue Sun und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Whether postoperative radiotherapy (RT) can be omitted in older women with hormone receptor–positive breast cancer remains controversial. We evaluated the association of RT with survival and breast cancer mortality using population-based SEER data.
Methods
Women aged ≥ 70 years with hormone receptor–positive T1– 2N0M0 breast cancer diagnosed in 2016– 2017 who underwent breast-conserving surgery were included. Propensity score matching and inverse probability of treatment weighting addressed measured confounding. Overall survival (OS) was assessed using Kaplan–Meier and Cox methods. Breast cancer–specific survival (BCSS) was evaluated using cause-specific Cox regression. Cumulative incidence functions and multivariable Fine–Gray regression were used to account for competing mortality.
Results
Among 8934 patients, 2591 matched pairs were obtained. At 60 months, OS was 88.8% with RT vs 82.3% without RT. RT was associated with lower all-cause mortality (HR=0.572, 95% CI 0.492– 0.664) and a lower cause-specific hazard of breast cancer death (csHR=0.414, 95% CI 0.276– 0.619). The cumulative incidence of breast cancer death was 1.33% vs 2.80%. Fine–Gray regression yielded an sHR of 0.442 (95% CI 0.295– 0.662; P< 0.001). Of 718 deaths in the matched cohort, 598 were confirmed other-cause deaths and 13 had unknown causes. Unknown-cause sensitivity analyses yielded similar estimates.
Conclusions
RT was associated with lower mortality and a lower cumulative incidence of breast cancer death in this observational cohort. Substantial competing mortality and residual treatment-selection bias warrant cautious interpretation; these associations do not establish a causal benefit.
Zitieren
APA
Sun, L., Jiang, X., Chen, Z., Chen, P., Li, Y., & Zhang, F. (2026). Adjuvant Radiotherapy and Survival After Breast-Conserving Surgery in Women Aged ≥70 Years with Hormone Receptor–Positive T1–2N0M0 Breast Cancer: A Propensity Score–Matched SEER Study. International Journal of Women's Health, Volume 18, 1-13. https://doi.org/10.2147/ijwh.s652389
Vancouver
Sun L, Jiang X, Chen Z, Chen P, Li Y, Zhang F. Adjuvant Radiotherapy and Survival After Breast-Conserving Surgery in Women Aged ≥70 Years with Hormone Receptor–Positive T1–2N0M0 Breast Cancer: A Propensity Score–Matched SEER Study. International Journal of Women's Health. 2026;Volume 18:1-13. doi:10.2147/ijwh.s652389
BibTeX
@article{Sun2026,
author = {Sun, Linyue and Jiang, Xinian and Chen, Ziyu and Chen, Peilin and Li, Yuanzhi and Zhang, Fenghua},
title = {Adjuvant Radiotherapy and Survival After Breast-Conserving Surgery in Women Aged ≥70 Years with Hormone Receptor–Positive T1–2N0M0 Breast Cancer: A Propensity Score–Matched SEER Study},
journal = {International Journal of Women's Health},
year = {2026},
volume = {Volume 18},
pages = {1--13},
doi = {10.2147/ijwh.s652389}
}
EUVIMED